BEDFORD, Mass., April 5 /PRNewswire/ -- Instrumentation Laboratory (IL), today announced its second ILluminations webinar, to be held on Wednesday, May 26, 2010 from 11:00 a.m. to 12:00 p.m. (ET). This web-based, Continuing Education seminar will feature Anthony E. Napolitano, M.D., presenting "Whole Blood Bilirubin Screening at the POC Improves Neonatal Outcomes and Workflow Efficiency."
This webinar will focus on the essential components for successful implementation and management of Total Bilirubin testing at the point-of-care. Hyperbilirubinemia and other jaundice-related illnesses can lead to costly hospital readmissions and increased patient risk. Dr. Anthony Napolitano, a specialist in Neonatology, will analyze current Bilirubin testing methodologies and discuss the impact of adding point-of-care, whole blood Total Bilirubin testing on workflow efficiencies and in improving patient outcomes. The program qualifies for 1.0 Professional Education Program hour through P.A.C.E.® (Professional Acknowledgement for Continuing Education) and the AARC (American Association for Respiratory Care).
"We are pleased to offer healthcare providers key educational information to address real issues they face in their hospitals every day," said Ramon Benet, Vice President of Worldwide Marketing and US Sales and Service at IL. "The ILluminations Webinar Series demonstrates our commitment to providing not only the best diagnostic solutions, but also, the most pertinent information and education for the improvement of patient care."
Registering to Attend
From now through May 24th, 2010, individuals worldwide can register to attend this webinar, online at: www.ilus.com/illuminations or by contacting their local IL sales representative. German language interpretation of the live presentation will also be available through a separate audio conference phone number, received upon registration.
Anthony E. Napolitano, M.D., serves as Medical Director at two partner institutions — All Children's
Hospital and Sarasota Memorial Hospital — in their renowned Neonatal/Pediatric departments. An active member of the American Board of Pediatrics, Dr. Napolitano is well versed in the key issues of patient management in both low and high-volume Neonatal Intensive Care Units. He currently serves in numerous additional capacities, beyond his duties as Medical Director — from Chairman of Infection Control to
Assistant Director of the Pediatric Pulmonary Function Lab. In addition to his clinical expertise, Dr. Napolitano has earned recognition for his teaching excellence. Currently, he is Clinical Associate Professor, Pediatrics, University of South Florida College of Medicine; and, previously, he served as Assistant Professor of Pediatrics, Medical College of Virginia. Over the past 20 years, Dr. Napolitano has co-authored an extensive number of clinical papers, published in a variety of journals including: Journal of Pediatrics, New England Journal of Medicine and Critical Care Medicine.
About the ILluminations Webinar Series
ILluminations Webinars are educational, web-based seminars led by industry experts and opinion leaders. The Series features timely topics and industry challenges that impact the effectiveness and success of healthcare. The first webinar in the Series featured Jeffrey C. Fried, M.D., presenting "Slaying Sepsis: Saving Lives for Faster and Bester Treatment." In 2010, the ILluminations Webinar Series for Critical Care includes three online events focused on improving clinical outcomes through point-of-care testing. All past ILluminations Webinars can be downloaded or streamed at www.ilus.com in the eLearning Center.
Instrumentation Laboratory (www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM® product offerings, part of the critical care line, include the new GEM Premier 3500 with Intelligent Quality Management (iQM®), GEM Premier™ 4000 analyzer, GEMweb Plus Custom Connectivity, and the GEM PCL Plus, a portable coagulation analyzer. IL's hemostasis portfolio includes the ACL TOP® Family of Hemostasis Testing Systems, fully automated, high-productivity analyzers, including the ACL TOP, the new ACL TOP LAS and the ACL TOP 500 CTS. IL also offers the new ACL AcuStar™, ACL ELITE® and ELITE PRO, other hemostasis analyzers and the HemosIL® line of reagents. IL is based in Bedford, Massachusetts.
The Instrumentation Laboratory logo, GEM, iQM, HemosIL, ACL TOP, ACL ELITE, ACL AcuStar and Premier are trademarks of Instrumentation Laboratory Company and/or one of its subsidiaries or parent companies, and may be registered in the United States Patent and Trademark Office and in other jurisdictions. All other product names, company names, marks, logos, and symbols are trademarks of their respective owners.
SOURCE Instrumentation Laboratory